Evidence mapPaperPMID 36933178Full record

ReviewDrugs & aging2023

Current Management of Hypertension in Older Adults.

Dimitrios G Chatzis, Kalliopi Magounaki, Ioannis Pantazopoulos, Eleftherios T Beltsios, Vasiliki Katsi, Konstantinos P Tsioufis

Abstract readReview
PubMed Publisher
In one paragraph

Review in Drugs & aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Withdrawal of antihypertensive drugs in older people.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dimitrios G ChatzisMedical School, European University Cyprus, 76 Siggrou avenue, 11742, Athens, Greece. dimitrioschatzis@yahoo.com.ORCID 0000-0003-1610-3736
Kalliopi MagounakiDepartment of Internal Medicine, KAT General Hospital of Athens, Athens, Greece.
Ioannis PantazopoulosDepartment of Emergency Medicine, Medical School, University of Thessaly, Larissa, Greece.
Eleftherios T BeltsiosDepartment of Thoracic and Cardiovascular Surgery, West Germany Heart Center, University Clinic Essen, Essen, Germany.
Vasiliki KatsiDepartment of Cardiology, School of Medicine, Ηippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Konstantinos P Tsioufis1st Cardiology Clinic, School of Medicine, Ηippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a major global health issue and it accounts for a big proportion of disability and mortality worldwide even in adults aged 65 years and above. Moreover, advanced age per se is an independent risk factor for adverse cardiovascular events and there is abundant scientific evidence supporting the beneficial effects of blood pressure lowering, within certain limits, in this subset of hypertensive patients. The aim of this review article is to summarize the available evidence regarding the appropriate management of hypertension in this specific subgroup, in an era of a constantly increasing aging population.

Indexed as

Antihypertensive AgentsHypertensionAgedAgingBlood PressureHumansRisk FactorsAntihypertensive Agents

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.